Amir Danino is the founder of INNOVENTRIC. INNOVENTRIC has raised $41M in total funding. Latest round: Series B. Based in Rehovot, Israel.
Amir Danino is the Founder & CEO of Innoventric, an Israeli medical device startup founded in 2017 that develops the Trillium™ catheter-based valve to treat tricuspid regurgitation. He has led the company through multiple funding rounds, including a $28.5M Series B in October 2024 led by RA Capital Management. Danino is based in Rehovot, Israel, where Innoventric is located at the Science Park.
Full founder directory · Investor directory · Company funding database · Fundraising library